will compounded glp 1 go away FDA is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified If it's not FDA-approved, it's
Description
We estimate that the cost of GLP-1 drugs for obesity is currently about 10% of total pharmacy spending
Earlier risk estimate: ~1 in 10,000 patients New finding: ~1 in 2,500 patients No known treatment for NAION Other reported conditions include optic nerve inflammation, maculopathy, and worsening diabetic retinopathy
Persistent dizziness that prevents you from performing daily tasks
Simply set it on the counter
